Androgel and Tysabri drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Androgel (testosterone) and Tysabri (natalizumab). Common drug interactions include gait disturbance among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Androgel and Tysabri. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Androgel?

Androgel has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 25,763 Androgel users. Check the latest studies of Androgel.

What is Tysabri?

Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. eHealthMe is studying from 221,369 Tysabri users. Check the latest studies of Tysabri.



On Aug, 09, 2026

19 people who take Androgel and Tysabri together, and have interactions are studied.

Androgel and Tysabri drug interactions.

What are the common drug interactions of Androgel and Tysabri, by gender? *:

female:

  1. Gait disturbance
  2. Haemoglobin decreased
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Rectal polyp (fleshy growth occurring on the lining of the colon)
  6. Vomiting
  7. Weight decreased
  8. Abdominal discomfort
  9. Abdominal pain upper
  10. Blood creatinine increased

male:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Anxiety
  4. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  5. Decreased interest
  6. Migraine (headache)
  7. Sinus disorder (disease of sinus)
  8. Aphasia (damage to the parts of the brain that control language)
  9. Back pain
  10. Completed suicide (act of taking one's own life)

What are the common drug interactions of Androgel and Tysabri, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  2. Fall
  3. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  4. Sinus disorder (disease of sinus)

40-49:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Back pain
  4. Bladder disorder
  5. Blood creatinine increased
  6. Cardiovascular disorder (heart diseases)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Dental caries
  9. Diarrhoea
  10. Drug ineffective

50-59:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Libido decreased (loss of interest in sex)
  3. Cholecystitis (infection of gallbladder)
  4. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  7. Epstein-barr virus antibody positive
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Haemoglobin decreased

60+:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Confusional state
  3. Loss of consciousness
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Abdominal discomfort
  6. Abdominal pain
  7. Affect lability (emotional incontinence)
  8. Affective disorder (mental disorder)
  9. Aggression
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. Blood Testosterone Decreased: 4 people, 21.05%
  2. Sleep Disorder: 2 people, 10.53%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.53%
  4. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 2 people, 10.53%
  5. Depression: 2 people, 10.53%
  6. Stress And Anxiety: 1 person, 5.26%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.26%
  8. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.26%
  9. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 5.26%
  10. Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Androgel and Tysabri?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Androgel and Tysabri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Androgel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tysabri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Androgel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tysabri and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on testosterone and natalizumab (the active ingredients of Androgel and Tysabri, respectively), and Androgel and Tysabri (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: